CIRS (mold illness) is not recognized as a medical diagnosis by mainstream medicine, stranding patients between doctors who dismiss them and practitioners who overtreat them

Chronic Inflammatory Response Syndrome (CIRS), the primary diagnosis given to patients who believe they are sick from mold exposure, is not considered an established medical diagnosis by mainstream academic medicine. UCLA Health published a direct statement that CIRS is not an established diagnosis. The diagnostic criteria, biomarkers, and treatment protocols all remain subjects of active debate. Yet an estimated 25% of the population carries HLA-DR gene variants that may make them susceptible to biotoxin-related illness, and many of these people experience real, debilitating symptoms — chronic fatigue, cognitive impairment, respiratory distress, joint pain — after documented mold exposure. This matters because patients are trapped in a no-man's land. Their primary care physician runs standard blood panels that come back normal and tells them nothing is wrong — or diagnoses them with depression, anxiety, chronic fatigue syndrome, or fibromyalgia. Desperate for answers, they find CIRS practitioners who charge $500-$1,500 per visit (rarely covered by insurance), order $2,000-$5,000 in specialty labs, and prescribe the Shoemaker Protocol — which is as disputed as the syndrome it treats. These patients spend $10,000-$50,000 out of pocket on treatment for a condition that half of medicine says does not exist, while experiencing symptoms that are undeniably real. This problem persists because the research funding for mold-related illness is minuscule compared to the problem's prevalence. The Shoemaker Protocol is documented in only 11 of 13 published articles reviewing CIRS treatments, providing a thin evidence base. Mainstream medicine's stance is that a lack of evidence is not evidence of absence, but until randomized controlled trials are funded and conducted, CIRS will remain in limbo — real enough to devastate patients' lives and finances, but not established enough for insurance coverage or standard medical treatment.